You need to enable JavaScript to run this app.
FDA encourages industry to adopt modeling tools to ensure stable processes
Regulatory News
Joanne S. Eglovitch
Compliance
North America
Pharmaceuticals
Product Lifecycle
Quality Assurance and Control
Regulatory Intelligence/Policy